InvestorsHub Logo
Followers 4
Posts 941
Boards Moderated 0
Alias Born 09/08/2015

Re: Benny7459 post# 90035

Friday, 08/26/2016 2:41:17 PM

Friday, August 26, 2016 2:41:17 PM

Post# of 427034
Pipelines, future potential, etc. When you go from that potential phase to the "been on the market for nearly 4 years" things change to a valuation based on actual sales. Many a biotech has traded sky high based on potential then came back to major reality once marketing begins.

Yeah, yeah, REDUCE-IT is on the way! Ok great, but that is a long way off and AMRN has a lot more cash to blow through and at least one more dilution as well, before REDUCE-IT comes along. Meanwhile the patent is one day closer to expiring every day. Will be years before any sort of approval for REDUCE-IT and by that time the patent life has shriveled away to a fraction of its original value.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News